Novo’s New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way.
The end of Novo Nordisk’s supply problems could bring new headaches for the rest of the pharmaceutical industry, which now ...
Wait—Ozempic Is Linked to ED?
AS GLP-1 AGONISTS soar in popularity—about 12 percent of the U.S. population has tried one, most often Ozempic or Wegovy ...
5 rules for holiday eating if you're taking a weight-loss drug
Weight-loss drugs like Ozempic can impact holiday eating. Doctors explain how to enjoy holiday foods without side effects and ...
BioSpace12h
Danish Regulators Flag Eye Risk for Novo’s Ozempic, Requesting EU Review
The Danish Medicines Agency had been watching reports of a rare eye disease in patients who took Novo’s GLP-1 drug but until ...
Sleep expert shares tips to wake up refreshed during the holidays
From using jet lag apps to soundproofing your room, Dr. Shelby Harris, psychologist and director of sleep at Sleepopolis, ...
Why the investor craze for Ozempic and rival weight-loss drugs may resume next year
Investors' focus could, however, shift back onto the possible market impacts of GLP-1 agonists in 2025, particularly as a result of a major expansion of current supplies after Novo Nordisk was given a ...
Novo Nordisk invests $1.2 bln in new rare disease drugs plant in Denmark
Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the ...
I poisoned myself with a weight-loss jab and thought I was dying. Six months later, I'm still battling a bizarre side-effect that's destroyed my willpower and made me wi…
It's been six months since I accidentally poisoned myself with a weight-loss jab I shouldn't have taken. But while the memory ...
Novo Nordisk invests $1.2 billion in new rare disease drugs plant in Denmark
STOCKHOLM/LONDON (Reuters) -Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in ...
Novo Holdings’ purchase of Catalent set to close after regulators’ green light
The $16.5 billion take-private deal can now be completed, and along with it Novo Nordisk’s related acquisition of three ...
The Peninsula18h
Weight-loss drugmaker Novo Nordisk invests $1.2 bn in new factory in Denmark
Copenhagen: Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight loss treatments Ozempic and Wegovy, said Monday it was investing ...